tiprankstipranks
Larimar Therapeutics provides update on nomlabofusp development
PremiumThe FlyLarimar Therapeutics provides update on nomlabofusp development
2M ago
Larimar Therapeutics reports Q4 EPS (30c), consensus (25c)
PremiumThe Fly
Larimar Therapeutics reports Q4 EPS (30c), consensus (25c)
2M ago
Larimar Therapeutics Reports Fourth Quarter and Full Year 2023 Operating and Financial Results and Provides Update on Nomlabofusp Development
PremiumPress Releases
Larimar Therapeutics Reports Fourth Quarter and Full Year 2023 Operating and Financial Results and Provides Update on Nomlabofusp Development
2M ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
2M ago
Larimar Therapeutics, Inc. (LRMR) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Larimar Therapeutics, Inc. (LRMR) Q4 Earnings Cheat Sheet
2M ago
Insider Trading: Larimar’s (NASDAQ:LRMR) Director Makes an Enormous Purchase
PremiumMarket News
Insider Trading: Larimar’s (NASDAQ:LRMR) Director Makes an Enormous Purchase
3M ago
Larimar Therapeutics 17.2M share Spot Secondary priced at $8.74
PremiumThe FlyLarimar Therapeutics 17.2M share Spot Secondary priced at $8.74
3M ago
Larimar Therapeutics files common stock, warrants offering
PremiumThe Fly
Larimar Therapeutics files common stock, warrants offering
3M ago
Larimar Therapeutics Announces Proposed Underwritten Public Offering
PremiumPress Releases
Larimar Therapeutics Announces Proposed Underwritten Public Offering
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100